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Fluorescence requenchingNaja atra cathelicidin (NA-CATH) is a 34-amino acid highly cationic peptide identiﬁed in Chinese cobras to pos-
sess potent toxicity against gram-negative and gram-positive bacteria and low toxicity against host cells. Here,
we report the NMR solution structure of the full-length NA-CATH peptide and its interaction with liposomes.
The structure shows a well-deﬁned α-helix between residues Phe3 to Lys23, on which one surface is lined by
the side-chains of one arginine and 11 lysine residues, while the other side is populated by hydrophobic residues.
The last eleven amino acids, which are predominately aromatic and hydrophobic in nature, have no deﬁned
structure. NMR data reveal that these residues do not interact with the hydrophobic residues of the helix,
indicating that the C-terminal residues have random conformations. Fluorescence requenching experiments, in
which liposomes serve as a mimic of the bacterial membranes, result in ﬂuorophore leakage that is consistent
with amembrane thinning or transient pore formationmechanism. NMR titration studies of the peptide–liposome
interaction reveal that the peptide is in fast exchange with the liposome, consistent with the ﬂuorescent studies.
These data indicate that full length NA-CATH possesses a helical segment and unstructured C-terminal tail that dis-
rupts the bilayer to induce leakage and lysing.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
Antimicrobial peptides (AMPs) are an essential component of
immune systems of living organisms, and exert a direct effect on a
broad spectrum of microbes including bacteria, fungi, and viruses
[1–4]. They also have awide variety of functionswithin the host, includ-
ing immunomodulatory and chemoattractant agents [5,6]. Several
AMPs have been shown to exhibit cytotoxic activity against cancer
cells and have shown promise as anticancer drugs [7]. Currently, there
are more than 2500 antimicrobial peptides identiﬁed and most are
often less than 100 amino acids and possess numerous cationic residues,
speciﬁcally lysine and arginine [1,8]. AMPs exhibit a diverse range of
amino acid sequences and structural properties. They are classiﬁed
into four groups based on structural themes: linear α-helical peptides,
linear extended peptides (with sequences dominated by a few types
of amino acids), peptides containing loop structures, and peptides
with structures constrained by intra-molecular disulﬁde bonds [9].
Given the wide range of attributes, structures, and sequences, AMPs
also exhibit various behaviors in their antibacterial role. Translocated
peptides into the bacterium lead to the disruption of cellular processes,
such as syntheses of nucleic acids, proteins, and cell walls [10–13]
and enzymatic activity [14] to name a few [11,15]. The most commondgill@gwu.edu (S.D. Gillmor).mode of action involves the disruption membrane function and integri-
ty [16–18]. In our system, we have reported that the cathelicidin, NA-
CATH, from the Naja atra snake, targets the membrane both in models
and in cell studies [19], leading us to investigate its structure and lysing
characteristics to clarify its behavior.
Within the general membrane disruption category, two primary
mechanisms are hypothesized: pore formation and disruption of mem-
brane integrity [1,9,17,20–35]. The Shai–Matsuzaki–Huang [36–39]
model suggests that the amphipathic AMPs must ﬁrst interact with
the membrane surface electrostatically, and then insert into the
membrane to form large pores [1,3,40]. In contrast, AMPs may exert
its bactericidal effect with a detergent-like “carpet mechanism” [37],
disrupting the structural properties of the membrane and resulting in
curvature strain, membrane thinning, short lived defects, transient
pores and even complete membrane dissolution [1,7,21,35,41,42].
Both mechanisms potentially lead to membrane depolarization, lipid
ﬂip-ﬂop accompanied by AMP translocation, lipid clustering, and
induced phase separation [7,43]. All of these effects are detrimental to
membrane functions. In our study, we employ a combination of NMR
and ﬂuorescence requenching assays to distinguish between these
two general models for NA-CATH, a highly cationic AMP.
The cathelicidin antimicrobial peptide obtained from the Naja atra
snake, NA-CATH, displays highly potent, high efﬁcacy behavior against
gram-negative and gram-positive bacteria, and even bioﬁlms [44] mak-
ing it a promising candidate to combat resistant bacterial strains. Impor-
tantly, it exhibits minimal cytotoxic effect against host cells [45–47].
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among the most cationic of AMPs [48]. Understanding NA-CATH
structure and general behavior is critical in determining how the
combination of charge, cooperativity and membrane interactions af-
fects AMP lysing capabilities.
Previous studies reveal a semi-conserved 11 amino-acid
(KRAKKFFKKLK-NH2) motif, ATRA-1A, that has antimicrobial activity
on its own, similar to the full length peptide [19]. This motif appears
twice within the sequence, with only a few differences in the non-
basic amino acids. Due to its length, ATRA-1A cannot span the
membrane bilayer nor can it form a barrel-stave pore. Therefore, it is
important to understand the structure and function of the full-length
NA-CATH to distinguish possible differences in the activity of the parent
and shortened peptide, as seen by Juba et al. [49].
Here, we describe the solution structure of the NA-CATH peptide by
NMR spectroscopy and a mechanism of action based on ﬂuorescence-
requenching studies and titration studies by NMR. The peptide adopts
an α-helical conformation between residues Phe3 and Lys23, while the
remaining C-terminal 11-amino acids remain unstructured. Peptide–
liposome binding studies show fast exchange between the peptide
and membrane. The ﬂuorescence and previous microscopy data give a
consistent picture of liposome disruption via thinning or transient
defects.
2. Experimental procedures
2.1. Materials
The peptides used in these studies were custom synthesized by
GenScript (Piscataway, NJ). The supplier reported purity of NA-CATH
was 95.0% based on high-performance liquid chromatography (HPLC)
analysis and veriﬁed by mass spectrometry. The following lipids were
purchased from Avanti Polar Lipids (Alabaster, AL) and used without
modiﬁcation: 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) and
1,2-dioleoyl-sn-glycero-3-phospho-(1′-rac-glycerol) (sodium salt)
(DOPG). The following materials were obtained from Invitrogen
(Carlsbad, CA): 8-aminonaphthalene-1,3,6-trisulfonic Acid, disodium
salt (ANTS) and p-xylene-Bis-pyridinium bromide (DPX). Sephadex®
G-25 Medium gel ﬁltration medium and 2,2,2-triﬂuoroethanol-d3
(TFE or d-TFE, 99.5% purity) were purchased from Sigma Aldrich
(St. Louis, MO) [22]. Heavywater or deuterium oxide (D2O, 99.8% purity)
waspurchased andusedwithoutmodiﬁcation fromAcros (Fair Lawn,NJ).
2.2. NMR spectroscopy
TheNMR samplewas prepared by dissolving 2.0mgof the lyophilized
peptide (NA-CATH, K1RFKKFFKKL10KNSVKKRAKK20FFKKPKVIGV30TFPF)
into 350 μL PBS buffer consisting of 90% H2O/10% D2O at pH 7.4 to yield
a ﬁnal concentration of ~1.5 mM. The sample was placed in a 5 mm
Shigemi tube. NMR data were acquired on a 600MHz Agilent NMR spec-
trometer equipped with a 5-mm triple-resonance z-axis gradient probe.
An initial two-dimensional (2D) 1H–1H NOESY spectrum of the
peptide in PBS buffer was acquired with mixing times of 100,150, and
200 msec at 21 °C. Initial evaluation of the data indicated that the
peptide did not have a stable structure because there were very little
1H–1H correlations from the NH protons. Subsequently, the peptide
sample was titrated with 2,2,2-triﬂuoroethanol-d3 (TFE) and the effect
on the peptide was evaluated by one-dimensional 1H NMR spectrum
at each 10% increment. The 2D 1H–1H NMR data presented here were
acquiredwith the peptide in 30% TFE. Previously, liposomes were titrat-
ed into the peptide sample to determine whether it would stabilize the
peptide structure. However, no stable structure was observed and the
titration instead caused liposome lysing.
Multiple 2D 1H–1H NOESY spectra were acquired with mixing times
of 100,150, and 200msec. The 2D TOCSY spectrumwas acquired using a
DIPSI-2 pulse train with a mixing time of 15 msec. A 2D DQF-COSYspectrum was acquired. The NMR data were processed by NMRpipe
[50] and analyzed with SPARKY [51] software packages.
For the structure calculation, restraints were based on NOEs
observed from the NOESY spectrum acquired with 100 msec mixing
time. The distance restraints used for the structure calculations were
grouped into three categories of 1.8–2.8 Å, 1.8–3.3 Å, and 1.8–5.0 Å
corresponding to NOE intensities of strong, medium, and weak, respec-
tively. Restraints based on NOEs to methyl and ambiguous germinal
methylene protons were assigned an additional 1.0 and 0.5 Å, respec-
tively. For restraints involvingNOEs for the aromatic side-chain protons,
2.3 Å was added to account for the pseudo-atom position for the δ- and
ε-protons.
A total of 399 NOE-derived restraints were used in the structure cal-
culations. All atoms of the peptide were included in the calculations.
Structures were computed using CYANA 2.1 [52] on an iMac Macintosh
computer operating with OSX 10.7. From a total of 30 randomly calcu-
lated structures, 10 were selected based on low target function values
of less than one and low RMSD values. Target function values, as output
by CYANA, reﬂect energetic inﬂuences due to violations for NOE, bond
length, VdW, and angles for the calculated structure. The low target
function values means that there were no violations beyond what is
accepted for a well-deﬁned structure by NMR spectroscopy. A total of
20,000 steps for torsion-angle simulated annealing were employed.
2.3. Liposome preparation
Large unilameller vesicles (LUV's, ~100 nm) were used to probe the
mechanism of interaction between the NA-CATH peptide and lipid ves-
icles. Liposomes are historically effective to employ as a membrane
mimic [53–63] and to probe protein–lipid interactions [42,54,55,
58–63]. Regular liposomes, needed for the peptide–liposome interac-
tion studies by 1H NMR, and ﬂuorophore loaded liposomes, used in
the ﬂuorescence requenching experiment were prepared as follows.
Lipids dissolved in chloroform were mixed together in a ratio of 80%
zwitterionic 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) to 20%
anionic 1,2-dioleoyl-sn-glycero-3-phospho-(1′-rac-glycerol) (sodium
salt) (DOPG) and dried under nitrogen and under vacuum for 2 h.
The vesicles were hydrated in PBS buffer (for NMR) or 10 mM HEPES/
70 mM KCl buffer (for ﬂuorescence assays) at pH 7. Loaded liposomes
for ﬂuorescence studies also contained the dye quencher pair 8-
Aminonaphthalene-1,3,6-trisulfonic acid, disodium salt and p-xylene-
Bis-pyridinium bromide (ANTS/DPX) at 10mM and 15mM respectively.
The freeze/thaw method was employed to ensure adequate encapsula-
tion of the dye and quencher. Brieﬂy, the vesicles were allowed to swell
for 5 min before being vortexed for 30 s. The vesicles were heated to
45 °C before undergoingﬁve freeze/thawcycles utilizing a dry ice/ethanol
bath for 3 min, followed by a 45 °C water bath for 5 min. Excess dye and
quencher molecules outside the loaded vesicles were removed by gel ﬁl-
tration using Sephadex G-25. This method produced a vesicle population
of 90% LUVs (50–1000 nm) and 10% SUVs (less than 20 nm) asmeasured
using Dynamic Light Scattering (Wyatt Technologies, Santa Barbara, CA).
Studies conducted on samples of 100% SUVs do not exhibit any leakage
(data not shown), therefore the presence of a small population of SUVs
does not affect the leakage data. Concentration of the loaded vesicle
was determined with a phosphate assay described elsewhere [64].
2.4. Peptide–liposome interaction by NMR spectroscopy
To test whether the α-helical peptide interacts with liposomes, we
titrated liposomes (80:20 DOPC:DOPG) into ~1.6 mM peptide in PBS
buffer with 30% TFE. The liposome was added in ~0.4 mM increments,
from a 30 mM stock, and interaction with the peptide was monitored
by chemical shift changes in the peptide 1H signals. We also performed
the liposome titration with peptide (0.25 mM) in PBS buffer without
TFE.
Fig. 1.NA-CATH peptide adopts a labile structure. A. The sequence of the peptide followed
by summary of the secondary structure prediction. A helix is predicted for residues Arg2 to
Lys23 and an extended structure is predicted for residuesVal27 to Thr31. The letters under
the sequence indicate the predicted secondary structure: C = coiled or unstructured
region, H = helix, and E = extended structure. B. One-dimensional 1H NMR spectra
showing the NH and aromatic proton region of NA-CATH in aqueous solution in the
absence (top spectrum) and presence of increasing concentration of 80:20
DOPC:DOPG liposomes. NA-CATH does not adopt a stable structure in aqueous solu-
tion and the similarity of the spectra indicates that most of the peptide remained un-
structured in liposomes. For clarity, the spectra are colored differently. Some of the
NH signals are identiﬁed and dashed lines how speciﬁc NH resonance shift with in-
creasing concentration of liposome.
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Fluorescence requenching studies, developed by Ladokhin et al. [65]
and usedby others [21,22,29,35,42] have been performed to identify the
leakage mechanism of action. For a detailed summary of the technique,
see Supplemental Figs. S1–S5. Brieﬂy, liposomes are loaded with ANTS
(ﬂuorescent dye) and DPX (quencher). When the peptide interacts
with the vesicles, leakage occurs, resulting in the separation of ANTS
and DPX and an increase in ﬂuorescence signal (Supplemental Fig. S1).
If the quenching inside the vesicles (Qin) changes due to a greater degree
of leakage ( fout) of the dye, then the release mechanism is considered
graded or gradual and Qin vs. fout will have the following relationship:
Qin ¼ 1þ Kd  DPX½ 0  1− f outð Þα
   1þ Ka  DPX½ 0  1− f outð Þα  −1:
ð1Þ
In the equation, Kd [DPX] is the dynamic quenching constant
(50 M−1), Ka [ANTS/DPX] is the association constant (490 M−1), [DPX]0 is
the initial concentration of entrapped DPX, and α is the preferential
release parameter. All values of α greater than zero are indicative of
graded release. If α is reduced to zero and Qin does not vary with fout,
then the leakage represents an all-or-none mechanism. Graded release
is an indication of membrane disruption, thinning or transient pore
formation, while all-or-none release occurs through pore formation or
vesicle lysis [65,66].
All ﬂuorescence studies have been performed using a Molecular
Devices SpectraMax M5 in which the ANTS dye is excited at 360 nm
and detected at 520 nm. All runs (n = 26) have been performed with
a lipid concentration of 100 μM and corrected for background ﬂuores-
cence. Loaded vesicles in 0.1% TWEEN-20 is used as a control because
it gives the maximum ﬂuorescence in the absence of quenching and is
used to calculate all Q values (Q [DPX] = F[DPX]/Fmax). Incremental addi-
tions of 1 M DPX to the lysed vesicles at 1 μL intervals have been
performed to prevent large volume changes, and provides the ﬂuores-
cence values needed to calculate Qout. The same procedure in buffer
with NA-CATH provides the ﬂuorescence values to calculate Qtotal. A
plot of Qtotal vs. Qout has been obtained for different peptide concentra-
tions and is ﬁtted to a line equation where the slope was fout, and b=
Q in(1 − fout). To account for incomplete entrapment, the Qtotal has
been measured in the absence of peptide, and the observed fout is
corrected with the following equation: fcor = ( fobs − fo)/(1− fo). The
Qin vs. fout ( fcor) correlation inwhich the [DPX]0 andα values are allowed
to vary, is ﬁtted to Eq. (1) using the Curve Fit Toolbox in Matlab.
Additionally, NA-CATH cooperativity is explored using a Hill plot
( fout vs. [NA-CATH]). Again, ﬁtting to the Hill equation ( fout = [P]n/
(K50n + [P]n)), where [P] is the concentration of the peptide (NA-
CATH), n is the Hill number, and K50 is the peptide concentration re-
quired for half-maximum leakage using the Curve Fit Toolbox inMatlab
determines if NA-CATH exhibits any positive cooperativity.
3. Results and discussion
The NA-CATH peptide is comprised of 34-amino acids and is derived
from Chinese cobra venom gland [44,48]. The peptide is one of themost
cationic of AMPs, consisting of two arginine and 13 lysine residueswith-
in the ﬁrst 26-amino acids (Fig. 1A). This region also consists of two
KKFFKK sequence repeats separated by ﬁve amino acids. There is a
hydrophobic residue roughly every three amino acids within this
26-amino acid region. The last 9 amino acids of the sequence are pre-
dominantly hydrophobic with two valine, an isoleucine, a proline, and
two phenylalanine residues. There are seven phenylalanine residues
in which three are located near the N-terminus, two within the middle
of the sequence, and two at the C-terminus. Interestingly, there are no
acidic amino acids within the sequence.Secondary prediction by Psipred [67] of the sequence suggests the
presence of an α-helix between residues Arg2 to Lys23 (Fig. 1A).
Residues Val27 to Thr31 are predicted to adopt an extended structure.
Previously, circular dichroism data have indicated that the peptide and
the shorter ATRA-1A construct adopt a stable helical conformation in
50% TFE [19,46].3.1. NMR studies of NA-CATH
In spite of the almost 1.5 mM peptide sample, the 1D 1H spectrum
of the peptide in aqueous solution shows very weak NH signals com-
pared with the aromatic signals within the downﬁeld (7–9 ppm) re-
gion (Fig. 1B). The 2D NOESY spectrum (100 msec mixing time) of
the peptide in aqueous solution does not contain any NH-NH(i,i ± 1)
or αH-NH(i,i ± 1) proton NOE characteristic of an α-helix or extended
structure, respectively (data not shown). Furthermore, there are
very few NH to side-chain proton–proton (1H–1H) correlations.
Together, these observations indicate that the peptide is highly labile
and does not have a stable structure and most of the NH protons are
rapidly exchanging with the aqueous solution. As a result, it would
not be possible to solve the structure of the peptide in aqueous solution.
Given that the peptide has been observed interacting with mem-
branes [19,44,46,49], we next have investigated whether the peptide
would adopt a stable structure in the presence of 80:20 DOPC:DOPG li-
posomes, which serve as a mimic of the bacterial membranes (Fig. 1B).
Interestingly, the NH region of the peptide shows very little chemical
shift and intensity changes. At 5–10×molar excess, there is some signal
broadening indicating that the peptide maybe interacting with
liposomes but not substantial broadened to conclude that the peptide
is embedded in liposomes. To verify that most of the peptide may be
free in solution and to identify its motion, we performed T1 and T2
relaxation measurements of the peptide in the presence and absence
of liposomes. Using the signals of methyl protons, the T1 and T2 values
under both conditions is estimated to be ~5.1 ± 0.4 s−1 and 1.9 ±
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the liposome. Furthermore, the similarity of NH signals in the absence
and presence of liposomes indicate that the peptide may not adopt a
stable structure in the presence of liposome.
Interestingly, upon raising the temperature of the peptide–liposome
sample to 37 °C, we have observed lipids ﬂoating at the top of the solu-
tion, consistent of compromised liposomes. A control experiment with
the same amount of liposomes in PBS at 37 °C, but without any peptide,
does not show compromised liposomes. In fact, the liposomes are, inFig. 2.NA-CATHpeptide is stabilizedby TFE. A. One-dimensional 1HNMRspectra showing the ef
10, and 0% TFE (top to bottom). B. Two 1H spectra showing theNH region of the peptide in TFE a
scale of the spectrumof thepeptide in liposomewithMn2+ is shown at 10×higher since N 90% o
well-resolved strong intensity 1H–1H NOE correlations deﬁning the residues adopting theα-he
the adjacent amino acids howbackboneNHprotons show theNH–NH(i,i + 1) NOEs are labeled. C
the intensity of theNOEs. Thick lines indicate strongNOEs,while the thin lines indicateweakNO
are shown. The CSI values are based on difference in chemical shift of the observed amino acid
resonances is consistent with the extensive sequential NOEs indicating the presence of an α-hgeneral, stable at 37 °C [53,57,61–63,68,69]. Similar results are observed
when the peptide is titrated with 30:20:50 DOPC:DOPG:DPPC and
50:30:20 DOPC:DPPC:DPPG di-phasic vesicles that contain both the
ﬂuid and gel phases coexisting together.
Given the larger number of basic residues, we have also titrated the
lipids with 50:50 DOPC:DOPG. The lines of the peptide resonances be-
come slightly broadened with increasing concentration of liposome,
but at 21 °C, the liposomes become compromised and we observe
both ﬂoating and precipitated lipids.fects of titrating of deuterated TFE on thepeptide. The four spectra show the effect of 30, 20,
nd liposome in the absence (top) and presence of 0.1mMparamagneticMn2+. The vertical
f the originalNH signals intensity havedecreased. Hα–NH(top) andNH–NH regions show
lical conformation. The intra-residue Hα resonances are labeled (top) while at the bottom,
. Summaryof backbone sequential NOEs are shownwith the thickness of the line reﬂecting
Es. At the bottomof theﬁgure, chemical shift index of theHα resonances for all aminoacids
with the corresponding amino acid in a random coil conformation. The upﬁeld shift in Hα
elix.
Table 1
Structure statistics for the solution structure of NA-CATH.
A. Restraint statistics
Intra-residue NOEs 208
Sequential NOEs (∣ i− j∣= 1) 90
Medium range NOEs (2 ≤ ∣i− j∣ ≤ 4) 101
Long range NOEs (∣i− j∣ N 4) 0
Total NOE restraints 399
Dihedral angle restraints 0
Total restraints 399
B. Ensemble statistics analysis
RMSD values (Å)
Backbone heavy atoms (3–22) 0.27 ± 0.08
All heavy atoms (3–22) 0.92 ± 0.1
C. Statistics from procheck (Ramachandran plot)
Residues in most favored regions (%) 81.4
Residues in additional allowed regions (%) 15.1
Residues in generously allowed regions (%) 3.1
Residues in disallowed regions (%) 0.3
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Since previous circular dichroism data have indicated that TFE
stabilizes the secondary structure of the peptide [46], we have titrated
deuterated TFE into the peptide. Indeed, we observe that the intensities
of the NH resonances increase, with the signals becoming sharper after
the ﬁrst three additions of 10% TFE (Fig. 2A). There are upﬁeld shifts of
the aromatic signals (6.8–7.3 ppm) as well as aromatic 1H signals
becoming better resolved. No further changes of signals are observed
for N30% TFE, indicating that the structure of the peptide is fully stabi-
lized in 30% TFE. The chemical shift changes and increases in sharpness
and the intensities of NH signals are considerably greater than those ob-
served when liposome is titrated into the peptide. Furthermore, the 2D
1H–1HNOESY spectrum shows strong intensity NHproton to side-chain
NOEs (Fig. 2B). Therefore, to characterize the structure of the peptide,
we have acquired 2D NMR data of the peptide in 30% TFE.
The complete 1HNMR resonance assignments are obtained based on
the NH–NH(i,i ± 1) and Hα–NH(i,i + 1) sequential NOE connectivities and
the NH-to-side chain 1H–1H correlations observed in the TOCSY and
COSY spectra [70]. As shownwith Fig. 2B,C, there are strong intensity se-
quential i,i+ 1 backboneNHprotonNOE correlations between adjacent
amino acids that allow for the connectivities of the various amino acid
spin patterns. There are strong intensity sequential NH–NH(i,i ± 1) and
weaker intensity NH–NH(i,i ± 2–4) NOEs consistent with an α-helix
formed by residues Phe3 to Lys23 (Fig. 2C). The intermediate intensity
Hα–Hβ(i,i + 3)1 H–1H NOEs observed for these residues supports the
presence of theα-helix. For residues Pro25–Phe34, no 1H–1HNOEs con-
sistent with a secondary structure are observed. These results indicate
that TFE serves to merely stabilize the structure of the peptide rather
than induce helical structure since the C-terminal residues remain
unstructured.
The backbone and side-chain protons for all but the N-terminal
lysine residue are identiﬁed. Strong intensity Hα–Hδ(i,i–1) proton NOEs
between the proline and the preceding amino acid indicate that the
two proline residues are in the trans-conformation. The signal disper-
sion of the amino acid spin-systems is sufﬁcient in the 2D NOESY and
TOCSY spectra to resolve the assigned amino acids. We have been able
to make backbone and side-chain atom NMR assignments for all but
the ﬁrst two amino acids. We are unable to assign 1Hε and guanidinium
protons of the arginine and the 1Hε and 1Hζ protons of lysine residues,
which are typically the case for these long side-chains that exhibit
mobility.
Chemical shift index (CSI) analysis is performed of the Hα reso-
nances because the peptide is unlabeled (Fig. 2C). It is not feasible to
acquire natural abundance 13C spectrum to obtain 13Cα chemical
shift for CSI analysis at such low peptide concentration. Nonetheless,
the Hα resonances are equally effective in identifying secondary
structure elements [71,72]. The Hα atoms chemical shifts are upﬁeld
shifted by an average of 0.3 ppm for residues Phe3–Lys23, conﬁrming
the α-helix identiﬁed by backbone NH–NH(i,i ± 1) sequential NOEs
(Fig. 2C) [72]. The Hα chemical shifts show alternating upﬁeld and
downﬁeld shifts for the last 11 residues, consistent with random or
labile structure.
3.3. Structure of NA-CATH
A total of 399 NOE-based restraints, obtained from the NOESY
spectra, are used to calculate the structure of the full-length peptide
(Table 1). Of these, 90 restraints are sequential, while 101 are medium
range (i,i + 2–4) restraints. These restraints and structural statistics
are summarized in Table 1. There are no long-range (i,i N 4) NOEs, con-
sistentwith a lack of a tertiary structure. Of the 30 structures calculated,
none has NOEs and angle violations greater than 0.20 Å and 3°, respec-
tively. There are also no vdw violations nor any deviations in bond
lengths. Ten ﬁnal structures are selected based on their lowest target
energies and the value of their backbone atom superposition. TheRMSD value for the superposition of the backbone heavy atoms for
residues Phe3 to Lys23 is 0.27 ± 0.08 Å, indicating that the α-helix is
well deﬁned (Fig. 3A(I)). The helix terminates at residue Lys24, which
precedes a proline residue. The relative positions for residues 1–2 and
25–34 are not deﬁned due to the lack of NOE-based restraints caused
by their structural mobility and lack of a stable structure (Fig. 3A(I,II)).
The RMSD value for the superposition of all heavy atoms for residues
Phe3 to Lys23 is 0.92 ± 0.1 Å. This slightly high RMSD value is largely
due to undeﬁned positions of the lysine and arginine side-chain Cε, Cζ,
and NH2 atoms, which are inherently mobile. Analyses of the 10 struc-
tures using Procheck [73] reveal that 81 % of amino acids have their di-
hedral angles within themost-favored region of the Ramachandran plot
(Table 1), while 15% are in the additionally allowed region. For the
residues within the α-helix, 95% is in the most-favored region, while
5% is in the additionally allowed region, indicating that the structure is
well deﬁned. Only one residue (Arg2) is observed in the unfavorable
region. This residue is not deﬁned in the structure calculations by any
NOE-based restraint.
A depiction of the structure from the side and helical region as a he-
lical wheel and the corresponding top-view of the α-helix (Fig. 3A(II),
B(I, II)) shows the basic residues encompassing more than half of the
surface of the helix. In the middle of the basic surface, a glutamine
residue (Gln12) separates the two KKFFKK sequence repeats. On the
opposite surface, hydrophobic residues, Phe-3, 6, 7, 21, and 22, line
more of the outer ridges on the helix (Fig. 3A(I)). The electrostatic
map of the helix shows two distinct surfaces, one dominated by basic
residues and the other by hydrophobic residues (Fig. 3A(I,II)).
3.4. Probing the interaction of NA-CATH and liposome by NMR
As noted, the majority of the peptide in aqueous solution does not
adopt a stable helical structure as it does in the presence of TFE. To un-
derstand how the full-length NA-CATH helical peptide may interact
membranes, we probe the interaction of the peptide in PBS buffer and
30% TFE with liposomes (80:20 DOPC:DOPG). For these studies, we
use higher concentrations of liposome (~mM range) than are typically
used by the ﬂuorescence requenching experiments because the concen-
tration of the peptide is higher and typically such binding studies
require at least 10× greater titrants, especially if the interaction is
weak. The higher concentrations of peptides and liposomes are also
required for detections by NMR spectroscopy.
Using 1D 1H NMR spectroscopy, we have followed chemical shift
changes of the peptide with increasing concentrations of liposome.
Fig. 4A reveals thatmost of theNHproton resonances showsmall chem-
ical shift changes. The NH protons of Phe3, Phe6, and Phe34 show
downﬁeld shifts with each titration point. The NH signals for Ala18,
Val14, and Val30 show upﬁeld shifts. The overlapping signals of the
Fig. 3. Structure of NA-CATH. A. Superposition of the backbone heavy atoms of residues Phe3 to Lys24 of 10 calculated structures. (I)Shown are backbone atoms only for residues in the
helical region, (II) the same superposition but the positions for residues 1–2 and 25 to 35, which are not well-deﬁned, are reﬂected by their random conformations. B. Helical wheel show-
ing position of the amino acids and the top-downview (N to C) of the calculated structure showing theposition of the side-chain residues. The orientation of thehelix correspondswith the
helical wheel. C. Two orientations of the helix showing the electrostatic surface; on the right, the surface is made transparent to illustrate the position of the helix. The scale depicts scale
from blue (basic residue) to red (acidic acid, electronegative). Blue color represents positive charged residues and the red color, here, indicates the backbone oxygen atoms. There are no
negatively charged amino acids. The hydrophobic surface has a gray or whitish hue.
2399H. Du et al. / Biochimica et Biophysica Acta 1848 (2015) 2394–2405aromatic side-chain 1Hδ/ε protons preclude analysis of the interaction
of speciﬁc aromatic residues with the liposome but the observed signal
broadening indicate that the aromatic residues are more involved withinteracting with the liposome. We posit that the C-terminal tail of pep-
tide becomes less mobile in the presence of the liposome, possibly with
interacting with the liposome.
Fig. 4.NMR studies of the peptide–liposome interaction. A. A series of 1D 1H spectra of the
peptide acquired with increasing concentration of liposomes are aligned. For clarity, the
spectra are colored differently. Some of the NH signals are identiﬁed and dashed lines
how speciﬁc NH resonance shift with increasing concentration of liposome. B. Two spectra
showing the NH region of the peptide in TFE and liposome in the absence (top) and
presence of 0.1 mM paramagnetic Mn2+. The spectrum of the peptide in liposome is also
shown at 10× lower level since N90% of the original NH signals have been broadened.
2400 H. Du et al. / Biochimica et Biophysica Acta 1848 (2015) 2394–2405We anticipate that if the peptide were binding strongly with the
surface of the liposome or were buried within the membrane, the
line-width of the peptide 1H signals would be substantially broadened
due to increased anisotropy. The overall line-widths of the 1Hresonances of the peptide remain relatively narrow and are comparable
to the peptide in TFE.
To further investigate the interaction of the peptide and liposome,
we have titrated paramagnetic MnCl2 into the ﬁnal peptide–liposome
mixture (Fig. 4B). We postulate that if the peptide were embedded in
the liposome the peptide signalswould be protected from the paramag-
netic effects of the manganese in solution [74]. After the ﬁrst addition
(0.1mMMnCl2), we estimate that N90% of the peptide 1H signals disap-
pear (Fig. 4B) indicating that most of the peptide is in solution. The
remaining very weak 1H signals suggest that a small percentage of the
peptide may be embedded in the lipid bilayer to be protected from
the paramagnetic effect of the manganese.
3.5. Fluorescence requenching experiments
In our recent study of NA-CATH and the shorter ATRA-1A, both
peptides exhibit membrane destructive behaviors: lysing, membrane
rearrangement, and content leakage [19]. However, it is unclear how
NA-CATH, with such cationic content, exerts its effect on membranes.
To probe a possible mechanism of action of the NA-CATH peptide with
lipid bilayers, we have performed ﬂuorescence requenching assays.
As noted, Ladokhin et al. [65] have developed a requenching proto-
col to differentiate between pore formation (all-or-none) and mem-
brane disruption (graded release), and this method has been widely
used by others to investigate how antimicrobial peptides initiate leak-
age [21,22,29,35,42]. Depending on the mechanism of leakage, the
signal inside the vesicles will change as well, and it is this interior
quenching (Qin) that allows for the differentiation of the two. For stable
pore formation, the contents inside each lysed vesiclewould be released
entirely (all-or-none). Any observed interior quenching (Qin) will be
from unlysed and unaffected vesicles. Therefore, interior quenching
will remain constant with increasing fractions of leakage, and the Qin
vs. fout plot will be a ﬂat line, consistent with observations made by
Gregory et al. for the pore-forming peptide cecropinA [22](Fig. S4). In
the case of membrane permeabilization, ANTS and DPX are expected
to diffuse across the membrane (graded release) and the interior con-
centrationswill changewith time. Themechanisms of permeabilization
could be throughmembrane thinning, othermembrane defects, or tran-
sient pores [29]. In this case, Qinwill increase as a function of ANTS and
DPX leakage, and their separation and concentration will decrease.
These events will increase ﬂuorescence and will result in an upward
sloping curve when Qin is plotted against fout, as was seen for the RTX
toxins— CyaA and HiYa [21], rabbit neutrophil defensins [42], bacterial
δ-lysin [41], and the cell penetrating peptide transportan 10 [35] (see
Fig. S5).
In order to calculate the interior quenching (Qin), we must deter-
mine the outside ﬂuorescence and quenching in detergent (Fout and
Qout) and total ﬂuorescence and quenching in buffer (Ftot and Qtot). In
Fig. 5A, the data show Qtotmeasured as a function of DPX concentration
at different peptide concentrations. The different curves correspond to
different lipid to peptide ratios in which the top line corresponds to
the most peptide present. The values of Qtot increase as the concentra-
tion of peptide increases, and it corresponds to greater leakage as a
function of peptide concentration.
The Qin value, which is quenching within the vesicle, is then deter-
mined by plotting Qtot as a function of Qout (Fig. 5B). Each data series
is ﬁtted to the linear equation, Qtot = Qout fout + Q in(1 − fout)
(seeAppendix A for the full derivation) revealing a linear correlation
between Q tot and Qout, and the values of Q in and fout for each lipid-
to-peptide ratio. The increasing slopes of the lines (red to black lines)
conﬁrm greater leakage as a function of peptide concentration. There-
fore, as the concentration of NA-CATH increases, the fraction of leakage,
or fout increases (Fig. 5C). The plot in Fig. 5C shows a hyperbolic relation-
ship that ﬁts well to the Hill equation (goodness-of-ﬁt of 0.925), with a
Hill coefﬁcient of n = 0.728 ± 0.062. This indicates that NA-CATH
peptides do not form dimer or oligomeric structures.
Fig. 5. Fluorescence Requenching Assay: A. Plot showing Qtot vs. [DPX] (mM), where Q tot = F/Fmax. As DPX is titrated into the samples, ﬂuorescence signal decreases because quenching
increases. This is seen as a decrease in Q tot. B. Q tot vs. Qout, where Q tot= F/Fmax in 0.1% TWEEN-20.When Q tot is plotted vs. Q tot it follows the relationship Q tot= Qout fout+ Q in (1− fout),
where fout is the fraction of ANTs leakage andQ in is the quenching inside the vesicle. Both are speciﬁc to a particular concentration of NA-CATH. The best ﬁt to this equation gives fout as the
slope, and Q in (1− fout) as the y-intercept. C. Lysing activity v. [NA-CATH]. As NA-CATH concentration increases, so does the fraction of ANTs leakage. From the slopes of the best ﬁts from
Fig. 3C, we form the plot fout vs. [NA-CATH] (μM), which shows lysing activity as a function of peptide concentration. The ﬁt of this new curve reveals the cooperativity of NA-CATH. Using
the Hill equation, we calculate its coefﬁcient, n = 0.73 (below 1), which indicates that NA-CATH peptides do not form dimer or oligomeric structures. D. Results of the ANTS/DPX
requenching assay showing the relationship of Q in vs. fout. By comparing the quenching inside the vesicles (Q in) and the degree of ﬂuorescence leakage ( fout) we see that graded release
ormembrane permeabilization is the predominantmechanism for NA-CATH. The ﬁt to Eq. (1) (alphaﬁt, blue line) ofQ in vs. fout data points shows thatQin increaseswith foutwithα=0.52
and [DPX]0=0.015M−1. Values forα b 1 suggest greater diffusion of ANTS across themembrane overDPX. Fitting the data to Eq. (2) (red curve) yielded an additional term (β), inwhichβ
is ratio of the ﬂuorescence release by both mechanisms. The ﬁt resulted in the following values: α= 0.52, [DPX]0 = 0.015 M−1, β= 0.070, f grad= 0.74, and f aon= 0.052. A β value b0.5
suggests the mechanism of ANTS leakage is via predominately graded, or membrane disruption.
2401H. Du et al. / Biochimica et Biophysica Acta 1848 (2015) 2394–2405In Fig. 5D, we compare Qin and fout values for different peptide
concentrations. As the fraction of ANTS molecules leaks out ( fout), Q in
increases, instead of remaining constant. The clear upward trend of
Qin is consistent with the graded release mechanism caused by general
membrane defects or transient pores, as opposed to all-or-none release
through stable pores or vesicle lysis. The best ﬁt of the data to Eq. (1)
(blue curve) with parameters KdDPX = 50 M−1 and KaANTS/DPX =
490M−1 provide values of α=0.52 and [DPX]0 = 0.015 M. The prefer-
ential release parameter, α, is less than one, indicating a preferential re-
lease of ANTS over DPX. This is similar to requenching results obtained
for the peptides δ-lysin and transportan 10, [35,41], where release has
been shown to be graded and preferential for ANTS.
The comparison of Q in and fout (Fig. 5D) shows variations in data
points around fout = 0.7. To understand the cause, we performed the
β analysis as described by Ladokhin et al. [65,66]. Themethod of analysis
assumes that the leakagemechanism is complex and is a combination of
graded and all-or-none release. Brieﬂy, the coefﬁcient, β, is deﬁned as
the preference for all-or-none release. Mathematically, it is deﬁned as
β= f aon/f grad, where f aon is the fraction of ANTS released by the all-or-
none mechanism, and f grad is the fraction of ANTS released by the grad-
ed mechanism. The two fractions are related to fout through thefollowing equation: fout= f aon + (1 − f aon)f grad. Rearrangement of
these relationships and substitution into Eq. (1) gives the following
new equation for Q in vs. fout that accounts for both mechanisms of
leakage:
Qin ¼ 1þ Kd DPX½ 0 1−
f out− f
gradβ
1− f gradβ
 !α !
1þ Ka DPX½ 0 1−
f out− f
gradβ
1− f gradβ
 !α !" #−1
:
ð2Þ
The best ﬁt of this equation to our data (Fig. 5D, red curve) using the
same parameters as used to ﬁt to Eq. (1), yield values of α = 0.52,
[DPX]0 = 0.015 M, β = 0.070, and f grad = 0.74. These values match
our previous calculations (α = 0.52 and [DPX]0 = 0.015 M). From
these ﬁndings, the f aon is calculated to be 0.052. Despite the value of
f aon indicating a small contribution from the all-or-none fraction, gener-
ally β values of less than 0.50 indicate a dominance of graded release
[65,66]. Therefore, our β value (0.070), which is signiﬁcantly less than
0.50, reveals that the mechanism of release is mostly graded caused
by membrane disruption.
2402 H. Du et al. / Biochimica et Biophysica Acta 1848 (2015) 2394–2405These ﬂuorescent data show an increase in internal vesicle
quenching consistentwith changes of the DPX andANTS concentrations
within the vesicle. These observations combinedwith those of the NMR
indicate that the leakage is due to disruption in the membrane
structure. Additionally, there is no indication of positive cooperativity
(Hill number, n b 1, see Fig. 5C) which would point towards stable
pore formation [21]. With a membrane-thinning model or transient
pore formation, we anticipate that the majority of the residues of the
peptide will partially or completely be positioned in solution due to
the loss of bilayer integrity. Membrane instability, in this case, enables
bilayer rearrangement consistent with our microscopy data for both
NA-CATH and ATRA-1A truncated peptide [19]. Our ﬂuorescence assays
span NA-CATH concentrations as high as 25 μM and they all indicate
general structural disruption and leakage over stable pore formation be-
havior. However, to obtain greater detail of the mechanism of action,
additional experiments such as neutron reﬂectometry, AFM, tagged
dextrans (ranging in size from 3 kD to 10 kD) leakage assays [29,34],
and other techniques [75–79], may be warranted but beyond the
scope of the current studies.
In the case of the 11 amino acid ATRA-1A sequence (KRAKKFFKKLK)
derived from NA-CATH, this peptide is too short to form a barrel-stave
pore. Given that the peptide is shown to form an α-helix by circular
dichroism in the presence of liposomes and shows similar lysing behav-
ior with ﬂuorescence microscopy [19], we postulate that the shorter
helix disrupts the lipid bilayer with a graded disruption mechanism,
similar to the full-length peptide. However, further studies are required
to investigate the exact mechanism of action given that the truncated
ATRA peptide lacks the long hydrophobic unstructured tail of NA-
CATH, which may aid in the binding and anchoring of NA-CATH in theFig. 6. Structural comparison of longα-helical antimicrobial peptides. Ribbon representation sh
colored blue and the hydrophobic residues are colored green.membrane [28]. Previous studies on other cathelicidin peptides have
shown that truncated versions of these sequences retain their activity
as well when the hydrophobic tail has been removed [80].
3.6. Structure and behavior of α-helical AMPs
There are numerous structures of short peptides with antibacterial
activity. Although it is beyond the scope of this article to evaluate all
of them, structural comparison of the NA-CATH peptide with some of
these antimicrobial α-helical peptides reveals a number of differences.
Within its class of α-helical AMPs, the NA-CATH helix is relatively
straight (Fig. 3A(II)), in contrast to curved helical structures [81–84]
and even helices separated by a helical turn[85]. For example, LL-37, a
single helical cathelicidin AMP, shows considerable curvature (Fig. 6).
It is not clear what contributes to the curvature in these structures.
Examination of the NMR data of NA-CATH does not reveal any inter-
residue side-chain proton NOEs that would indicate a curvature in the
helix. The peptide structure is calculated without H-bond restraints,
which can be more restrictive than those of the NOEs.
Additional differences in the structural properties of NA-CATH struc-
ture are evident when comparedwith other helical AMP peptides. First,
the NA-CATH peptide is highly cationic with 15 lysine and arginine
residues. These residues of NA-CATH are uniformly distributed along
one surface of the peptide (Fig. 3A(II) & B), with most located on one
surface of the helix. The hydrophobic residues are distributed along
the opposite surface. The last nine C-terminal amino acids are predom-
inantly hydrophobic and unstructured, in contrast to similar α-helical
AMPs [81–85]. The few lysine and arginine residues of LL-37 (PDB:
2K6O, [84]) are located not only on the convex surface, but also on theowing two orientations of the (A) NA-CATH, (B) LL-37. The arginine and lysine residues are
2403H. Du et al. / Biochimica et Biophysica Acta 1848 (2015) 2394–2405outer edges of the helix (Fig. 6). In the LL-37 structure, a number of glu-
tamate and asparate residues are strategically located straight along the
convex surface, and this may inﬂuence the separation of the basic
residues (Fig. 6). The hydrophobic residues of LL-37 are located along
the concave surface.
For NA-CATH, the ﬂuorescence data provide strong evidence of
a membrane disruption mechanism of action through membrane
thinning, defects, or transient pore formation, consistent with
observation and previous requenching results for δ-lysin and
transportan 10 [35,41]. With stable pore formation, one would ex-
pect a pattern of shielded residues, embedded in the bilayer, which
is inconsistent with our NMR ﬁndings. Curved helical AMP confor-
mations, unlike the NA-CATH NMR solution, have a propensity for
pore formation [81,86] or are predicted to do so based on their struc-
ture [26,82]. According to Lad et al. [24] and Gazit et al. [87], the
helix-break/bend-helix structures allow for the ﬂexibility required
to penetrate the bilayer. In contrast, long straight helical AMPs
show parallel binding to the membrane leading to its disruption
[20,87]. Therefore, the carpet mechanism or transient pores are like-
ly leakage mechanisms for such AMPs. The straight helical structure
of NA-CATH suggests that the membrane disruption behavior may
follow this pattern.
As noted, NA-CATH has the highest positive charge of any of the
peptides mentioned and this may promote interaction with the lipid
headgroups and deter NA-CATH from imbedding deep in the bilayer.
Such behavior ﬁts will with the NMR peptide–liposome interaction
experiments showing that signiﬁcant portion of the peptide lies in solu-
tion, consistentwith a compromised bilayer. Furthermore, the liposome
may induce a helical structure that is too transient to be detected by
NMR spectroscopy. Our previous lysing studies of the ATRA-1A peptide
show similar microscopy behavior to the parent (NA-CATH) in terms
of bilayer rearrangement and vesicle fusion, both indicators of bilay-
er instability [19]. Given the NMR and requenching data from our
present investigations, the most reasonable explanation for both
NA-CATH and ATRA-1A is through membrane defects or transient
pore formation.4. Conclusion
In these studies, we characterize the structure of the 34-amino acid
NA-CATH peptide consisting of 15 positively charged amino acids. The
region encompassing these charged residues adopts a helical conﬁrma-
tion. The NA-CATH structure appears to be similar to previous straight
α-helical AMPs and there is strong evidence supporting a membrane
disruption behavior via membrane thinning, defects, transient pores,
and carpet model dissolution [20,23,32,88]. Our ﬂuorescence and mi-
croscopy data indicate that NA-CATH functions in a similar manner.
The peptide–liposome interactions probed by NMR spectroscopy reveal
that a signiﬁcant portion of the peptide lies in solution, consistentwith a
compromised bilayer. While NMR data suggest fast binding, it is possi-
ble that the disruption process occurs too rapidly to be observable by
NMR spectroscopy. The ﬂuorescence requenching studies on the other
hand are able to provide insights into the mechanism of action of the
peptide and complement theNMRdata.We postulate from these obser-
vations, that the peptide adopts a labile structure, becoming helical
when brieﬂy bound to the liposome and lyses via membrane disruption
and transient pores. However, additional studies are warranted for
greater details of membrane disruption mechanism and the role the
peptide structure plays in this function.Transparency document
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Appendix A
In their 1997 paper, Ladokhin et al. presented the theory on differen-
tiating between pore or graded mechanism using the ANTS/DPX dye/
quencher pair and the following mathematical relationships.
Let Ftot ¼ Fout þ Fin; ðA1Þ
where Ftot is the total ﬂuorescence signal from inside and outside the
vesicles. The relationship between the quenching total, quenching
inside and outside the liposomes (Qtot,Qin andQout) andhow they affect
the ﬂuorescence signal are not simply additive. We solve for their
relationship below.
Due to the presence of DPX, both Fout and Fin experience quenching,
so that
Fout ¼ Qout Fmaxout and Fin ¼ Qin Fmaxin ðA2Þ
where,Qout andQin are quenchingboth inside andoutside the liposomes
and Fmax is the maximum possible ﬂuorescence signal.
From combining Eqs. (A1) and (A2) we ﬁnd:
Ftot ¼ Qout Fmaxout þ Qin Fmaxin : ðA3Þ
If we divide Eq. (A3) by Fmax then
Ftot
Fmax
¼ Qout
Fmaxout
Fmax
þ Qin
Fmaxin
Fmax
ðA4Þ
where, the total quenching is
Qtot ¼
Ftot
Fmax
: ðA5Þ
In the absence of quenching, Ftot= Fmax, therefore Ftot/Fmax=1, thus
allowing us to deﬁne:
f out ¼
Fmaxout
Fmax
; f in ¼
Fmaxin
Fmax
; and f out þ f in ¼ 1: ðA6Þ
By substituting Qtot (A5) and the fractions of dye (A6) into Eq. (A4),
we then identify the quenching relationships.
Qtot ¼ Qout f out þ Qin f in: ðA7Þ
Further, if we simplify the expression using fin = 1− fout, then
Qtot ¼ Qout f out þ Qin 1− f outð Þ: ðA8Þ
Appendix B. Supplementary data
We have included Figs. S1–S5 to provide clarity to the requenching
assay data. This material is available via the Internet at http://www.
sciencedirect.com. Supplementary data to this article can be found
online at http://dx.doi.org/10.1016/j.bbamem.2015.07.006.
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